Clinical Updates

Pain-killing medicine is often withheld during painful and stressful procedures performed on critically ill newborn infants in intensive care units,… »   

Bone growth products made by Medtronic Inc and Stryker Corp have been linked to life-threatening complications when used without approval… »   

General anesthesia during surgery may increase patients’ pain after they regain consciousness, U.S. researchers said on Monday.

They… »   

U.S. drug regulators are close to allowing doctors to electronically prescribe potentially addictive medications like painkillers, rather than requiring written… »   

Medicine has moved a little bit closer to the era of tailor-made treatments, based on the unique genetic profiles of… »   

Johnson & Johnson’s experimental drug ustekinumab should be approved for treating adults with moderate or severe psoriasis, a U.S. advisory… »   

Britain’s Department of Health has picked GlaxoSmithKline’s cervical cancer vaccine Cervarix over Merck’s Gardasil for its immunisation programme, Glaxo said… »   

Thirty percent of rheumatoid arthritis patients who failed to respond adequately to anti-TNF therapy achieved remission from their disease when… »   

Paris, France, Friday 13 June 2008: New data presented today at EULAR 2008, the Annual Congress of the European League… »   

A nearly 7-year study of the effect of intensive blood sugar control with rosiglitazone (Avandia, GlaxoSmithKline) on the progression… »   

An experimental treatment for rheumatoid arthritis being developed by Johnson & Johnson and Schering-Plough Corp appeared to be effective… »   

Roche Holding AG’s MabThera was more effective in treating rheumatoid arthritis (RA) patients than other drugs with a more traditional… »   

An experimental injectable type 2 diabetes drug being developed by Sanofi-Aventis SA was well tolerated and significantly improved blood sugar… »   

Sanofi-Aventis SA’s drug Acomplia can significantly improve blood sugar control in patients with type 2 diabetes who are not adequately… »   

The chief executive of Allergan Inc said Wednesday its experimental drug to promote eyelash growth could be a big seller… »